UK markets open in 4 hours 3 minutes
NIKKEI 225
36,818.81 -1,260.89 (-3.31%) HANG SENG
16,139.93 -245.94 (-1.50%) CRUDE OIL
86.07 +3.34 (+4.04%) GOLD FUTURES
2,418.50 +20.50 (+0.85%) DOW
37,775.38 +22.07 (+0.06%) Bitcoin GBP
49,258.33 -500.95 (-1.01%)
Celldex Therapeutics, Inc. (CLDX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.60B |
| Enterprise value | 2.18B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 278.95 |
| Price/book (mrq) | 6.07 |
| Enterprise value/revenue | 317.10 |
| Enterprise value/EBITDA | -15.70 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.56 |
| 52-week change 3 | 5.22% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 53.18 |
| 52-week low 3 | 22.11 |
| 50-day moving average 3 | 41.94 |
| 200-day moving average 3 | 34.28 |
Share statistics
| Avg vol (3-month) 3 | 944.09k |
| Avg vol (10-day) 3 | 582.31k |
| Shares outstanding 5 | 65.7M |
| Implied shares outstanding 6 | 65.7M |
| Float 8 | 52.74M |
| % held by insiders 1 | 0.35% |
| % held by institutions 1 | 96.80% |
| Shares short (28 Mar 2024) 4 | 6.56M |
| Short ratio (28 Mar 2024) 4 | 5.5 |
| Short % of float (28 Mar 2024) 4 | 11.44% |
| Short % of shares outstanding (28 Mar 2024) 4 | 9.98% |
| Shares short (prior month 29 Feb 2024) 4 | 6.41M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 11 Feb 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 11 Feb 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -850.33% |
Management effectiveness
| Return on assets (ttm) | -21.70% |
| Return on equity (ttm) | -37.45% |
Income statement
| Revenue (ttm) | 6.88M |
| Revenue per share (ttm) | 0.14 |
| Quarterly revenue growth (yoy) | 156.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -139.03M |
| Net income avi to common (ttm) | -141.43M |
| Diluted EPS (ttm) | -2.92 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 423.6M |
| Total cash per share (mrq) | 7.58 |
| Total debt (mrq) | 2.54M |
| Total debt/equity (mrq) | 0.59% |
| Current ratio (mrq) | 13.87 |
| Book value per share (mrq) | 7.68 |
Cash flow statement
| Operating cash flow (ttm) | -107.29M |
| Levered free cash flow (ttm) | -46.7M |
© 2024 Yahoo. All rights reserved.